IMPALA Consortium will be attending DIA 2023 in June in three sessions featuring speakers from member companies of IMPALA. we will have three sessions with speakers from companies that are members of the industry group.
Check out the sessions below and register here to attend the sessions!
Session #157: IMPALA (IntercoMPany quALity Analytics) Industry Consortium: Quality Analytics Use Cases and Early Health Authority Feedback
𝘛𝘩𝘪𝘴 𝘧𝘰𝘳𝘶𝘮 𝘸𝘪𝘭𝘭 𝘱𝘳𝘦𝘴𝘦𝘯𝘵: 1) 𝘵𝘩𝘦 𝘷𝘪𝘴𝘪𝘰𝘯 𝘰𝘧 𝘐𝘔𝘗𝘈𝘓𝘈 𝘢𝘯𝘥 𝘦𝘹𝘢𝘮𝘱𝘭𝘦𝘴 𝘰𝘧 𝘐𝘔𝘗𝘈𝘓𝘈’𝘴 𝘲𝘶𝘢𝘭𝘪𝘵𝘺 𝘢𝘯𝘢𝘭𝘺𝘵𝘪𝘤𝘴 𝘱𝘳𝘰𝘥𝘶𝘤𝘵𝘴, 2) 𝘰𝘯𝘨𝘰𝘪𝘯𝘨 𝘧𝘦𝘦𝘥𝘣𝘢𝘤𝘬 𝘧𝘳𝘰𝘮 𝘩𝘦𝘢𝘭𝘵𝘩 𝘢𝘶𝘵𝘩𝘰𝘳𝘪𝘵𝘪𝘦𝘴 𝘰𝘯 𝘵𝘩𝘦 𝘲𝘶𝘢𝘭𝘪𝘵𝘺 𝘢𝘯𝘢𝘭𝘺𝘵𝘪𝘤𝘴 𝘮𝘦𝘵𝘩𝘰𝘥𝘴, 𝘢𝘯𝘥 3) 𝘨𝘶𝘪𝘥𝘢𝘯𝘤𝘦 𝘰𝘯 𝘩𝘰𝘸 𝘴𝘱𝘰𝘯𝘴𝘰𝘳𝘴 𝘢𝘯𝘥 𝘳𝘦𝘨𝘶𝘭𝘢𝘵𝘰𝘳𝘴 𝘤𝘢𝘯 𝘫𝘰𝘪𝘯 𝘐𝘔𝘗𝘈𝘓𝘈.
Chair: Michael Torok, Ph.D. (Genentech)
IMPALA speakers: Lorraine Fay (Bristol Myers Squibb), Haleh Valian PhD (Biogen) and Robert Studt (Johnson & Johnson)
Session #108: Data Analytics for Quality Assurance: Shifting the Paradigm from Issue Detection to Quality Evidence Generation
𝘏𝘰𝘸 𝘥𝘰 𝘺𝘰𝘶 𝘴𝘰𝘭𝘷𝘦 𝘤𝘰𝘮𝘱𝘭𝘦𝘹 𝘎𝘊𝘗/𝘗𝘝 𝘲𝘶𝘢𝘭𝘪𝘵𝘺 𝘢𝘴𝘴𝘶𝘳𝘢𝘯𝘤𝘦 (𝘘𝘈) 𝘱𝘳𝘰𝘣𝘭𝘦𝘮𝘴? 𝘏𝘰𝘸 𝘵𝘰 𝘥𝘦𝘵𝘦𝘤𝘵 𝘢𝘯𝘥 𝘮𝘪𝘵𝘪𝘨𝘢𝘵𝘦 𝘪𝘴𝘴𝘶𝘦𝘴 𝘧𝘢𝘴𝘵𝘦𝘳, 𝘳𝘦𝘥𝘶𝘤𝘦 𝘵𝘩𝘦 𝘣𝘶𝘳𝘥𝘦𝘯 𝘰𝘧 𝘳𝘦𝘵𝘳𝘰𝘴𝘱𝘦𝘤𝘵𝘪𝘷𝘦, 𝘵𝘪𝘮𝘦-𝘤𝘰𝘯𝘴𝘶𝘮𝘪𝘯𝘨 𝘵𝘳𝘢𝘥𝘪𝘵𝘪𝘰𝘯𝘢𝘭 𝘘𝘈 𝘢𝘤𝘵𝘪𝘷𝘪𝘵𝘪𝘦𝘴? 𝘏𝘰𝘸 𝘤𝘢𝘯 𝘢𝘥𝘷𝘢𝘯𝘤𝘦𝘥 𝘢𝘯𝘢𝘭𝘺𝘵𝘪𝘤𝘴 𝘣𝘦 𝘭𝘦𝘷𝘦𝘳𝘢𝘨𝘦𝘥 𝘵𝘰 𝘶𝘭𝘵𝘪𝘮𝘢𝘵𝘦𝘭𝘺 𝘢𝘤𝘤𝘦𝘭𝘦𝘳𝘢𝘵𝘦 𝘢𝘱𝘱𝘳𝘰𝘷𝘢𝘭 𝘢𝘯𝘥 𝘱𝘢𝘵𝘪𝘦𝘯𝘵 𝘢𝘤𝘤𝘦𝘴𝘴 𝘵𝘰 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘷𝘦 𝘥𝘳𝘶𝘨𝘴? 𝘐𝘯 𝘵𝘩𝘪𝘴 𝘴𝘦𝘴𝘴𝘪𝘰𝘯, 𝘢𝘥𝘷𝘢𝘯𝘤𝘦𝘥 𝘢𝘯𝘢𝘭𝘺𝘵𝘪𝘤𝘴 (𝘦.𝘨. 𝘔𝘢𝘤𝘩𝘪𝘯𝘦 𝘓𝘦𝘢𝘳𝘯𝘪𝘯𝘨, 𝘕𝘢𝘵𝘶𝘳𝘢𝘭 𝘓𝘢𝘯𝘨𝘶𝘢𝘨𝘦 𝘗𝘳𝘰𝘤𝘦𝘴𝘴𝘪𝘯𝘨) 𝘶𝘴𝘦𝘴 𝘤𝘢𝘴𝘦𝘴 𝘸𝘪𝘭𝘭 𝘣𝘦 𝘴𝘩𝘢𝘳𝘦𝘥 𝘢𝘯𝘥 𝘥𝘪𝘴𝘤𝘶𝘴𝘴𝘦𝘥 𝘣𝘺 𝘥𝘢𝘵𝘢 𝘴𝘤𝘪𝘦𝘯𝘵𝘪𝘴𝘵𝘴 𝘸𝘰𝘳𝘬𝘪𝘯𝘨 𝘸𝘪𝘵𝘩𝘪𝘯 𝘙&𝘋 𝘘𝘶𝘢𝘭𝘪𝘵𝘺 𝘖𝘳𝘨𝘢𝘯𝘪𝘻𝘢𝘵𝘪𝘰𝘯𝘴 𝘰𝘧 𝘵𝘩𝘳𝘦𝘦 𝘣𝘪𝘰𝘱𝘩𝘢𝘳𝘮𝘢 𝘴𝘱𝘰𝘯𝘴𝘰𝘳𝘴. 𝘍𝘳𝘰𝘮 𝘱𝘳𝘰𝘣𝘭𝘦𝘮 𝘪𝘥𝘦𝘯𝘵𝘪𝘧𝘪𝘤𝘢𝘵𝘪𝘰𝘯 𝘵𝘰 𝘪𝘮𝘱𝘭𝘦𝘮𝘦𝘯𝘵𝘪𝘯𝘨 𝘢𝘥𝘷𝘢𝘯𝘤𝘦𝘥 𝘢𝘯𝘢𝘭𝘺𝘵𝘪𝘤𝘴 𝘵𝘩𝘢𝘵 𝘤𝘢𝘯 𝘣𝘦 𝘭𝘦𝘷𝘦𝘳𝘢𝘨𝘦𝘥 𝘣𝘺 𝘲𝘶𝘢𝘭𝘪𝘵𝘺 𝘱𝘳𝘰𝘧𝘦𝘴𝘴𝘪𝘰𝘯𝘢𝘭𝘴, 𝘬𝘦𝘺 𝘴𝘵𝘦𝘱𝘴 𝘤𝘳𝘪𝘵𝘪𝘤𝘢𝘭 𝘵𝘰 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘪𝘯𝘨 𝘢𝘥𝘷𝘢𝘯𝘤𝘦𝘥 𝘢𝘯𝘢𝘭𝘺𝘵𝘪𝘤𝘴 𝘧𝘰𝘳 𝘎𝘊𝘗/𝘗𝘝 𝘘𝘈 𝘸𝘪𝘭𝘭 𝘣𝘦 𝘳𝘦𝘷𝘪𝘦𝘸𝘦𝘥. 𝘍𝘪𝘯𝘢𝘭𝘭𝘺, 𝘸𝘦 𝘸𝘪𝘭𝘭 𝘥𝘪𝘴𝘤𝘶𝘴𝘴 𝘩𝘰𝘸 𝘪𝘯𝘴𝘪𝘨𝘩𝘵𝘴 𝘨𝘦𝘯𝘦𝘳𝘢𝘵𝘦𝘥 𝘧𝘳𝘰𝘮 𝘢𝘯𝘢𝘭𝘺𝘵𝘪𝘤𝘴 𝘤𝘢𝘯 𝘣𝘦 𝘶𝘴𝘦𝘥 𝘵𝘰 𝘨𝘦𝘯𝘦𝘳𝘢𝘵𝘦 𝘘𝘈 𝘦𝘷𝘪𝘥𝘦𝘯𝘤𝘦.
Chair: Timothé Ménard (Roche)
IMPALA speakers: Meera Nagaria (Johnson & Johnson), Kelly Kwon (Genentech) and Hangyu (Cedric) Liu (Biogen)
Session #223: One Year On: How Quality Briefs are Transforming the Approach to Quality and Driving Innovation to Serve Patients
𝘛𝘩𝘪𝘴 𝘴𝘦𝘴𝘴𝘪𝘰𝘯 𝘸𝘪𝘭𝘭 𝘪𝘯𝘤𝘭𝘶𝘥𝘦 𝘢 𝘧𝘰𝘤𝘶𝘴𝘦𝘥 𝘥𝘪𝘴𝘤𝘶𝘴𝘴𝘪𝘰𝘯 𝘰𝘯 𝘪𝘯𝘥𝘶𝘴𝘵𝘳𝘺/ 𝘩𝘦𝘢𝘭𝘵𝘩 𝘢𝘶𝘵𝘩𝘰𝘳𝘪𝘵𝘺 𝘤𝘰𝘭𝘭𝘢𝘣𝘰𝘳𝘢𝘵𝘪𝘰𝘯 𝘰𝘷𝘦𝘳 2022-2023 𝘰𝘯 𝘵𝘳𝘢𝘯𝘴𝘧𝘰𝘳𝘮𝘪𝘯𝘨 𝘵𝘩𝘦 𝘴𝘵𝘢𝘯𝘥𝘢𝘳𝘥 𝘢𝘱𝘱𝘳𝘰𝘢𝘤𝘩 𝘵𝘰 𝘲𝘶𝘢𝘭𝘪𝘵𝘺: 𝘦𝘯𝘢𝘣𝘭𝘪𝘯𝘨 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯 𝘣𝘺 𝘮𝘪𝘵𝘪𝘨𝘢𝘵𝘪𝘯𝘨 𝘳𝘪𝘴𝘬𝘴 𝘶𝘴𝘪𝘯𝘨 𝘲𝘶𝘢𝘭𝘪𝘵𝘺 𝘣𝘳𝘪𝘦𝘧𝘴 𝘵𝘰 𝘣𝘶𝘪𝘭𝘥 𝘵𝘳𝘶𝘴𝘵 𝘢𝘯𝘥 𝘤𝘰𝘯𝘧𝘪𝘥𝘦𝘯𝘤𝘦, 𝘸𝘪𝘵𝘩 𝘰𝘶𝘵𝘤𝘰𝘮𝘦𝘴-𝘣𝘢𝘴𝘦𝘥 𝘵𝘳𝘢𝘯𝘴𝘱𝘢𝘳𝘦𝘯𝘤𝘺.
IMPALA speaker: Paula Walker (Roche)
